Evidence map›Paper›PMID 30742636›Full record

ArticlePloS one2019

Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital.

Prameet M Sheth, Katya Douchant, Yvonne Uyanwune, Michael Larocque, Arravinth Anantharajah, Emily Borgundvaag, Lorraine Dales, Liz McCreight, Laura McNaught, Christine Moore and 3 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Optimized Surveillance Testing for ToxigenicmedRxiv : the preprint server for health sciences · 2026
    Article
  3. Impact of admission screening onInfection control and hospital epidemiology · 2026
    Article
  4. Article
  5. The Role ofMicroorganisms · 2025
    Review
  6. Article
  7. Emerging Diagnostics inInternational journal of molecular sciences · 2024
    Review
  8. "Antibiotics (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Neutralising Effects of Different Antibodies onInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Review
  16. Comparative genomic and transmission analysis ofEmerging microbes & infections · 2021
    Article
  17. Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  18. Anti-virulence strategies forGut microbes · 2020
    Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Prameet M ShethDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Katya DouchantDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Yvonne UyanwunePublic Health Ontario Laboratories, Toronto, Ontario, Canada.
Michael LarocqueDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Arravinth AnantharajahDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Emily BorgundvaagDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Lorraine DalesDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Liz McCreightDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Laura McNaughtDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Christine MooreDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Kelsey RaganDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
Allison McGeerDepartment of Microbiology, Mt Sinai Hospital, Toronto, Ontario, Canada.
George BroukhanskiPublic Health Ontario Laboratories, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClostridium difficile (CD) is the leading cause of infectious health-care associated diarrhea. However, little is known regarding CD carriage and transmission amongst asymptomatic colonizers. We evaluated carriage, characterized strains and examined epidemiologic linkages in asymptomatic colonized CD patients.

methodsRectal swabs from asymptomatic patients admitted to the general medicine ward from April 1-June 30 2012 were collected. PCR-confirmed CD colonies were ribotyped and characterized by Modified-Multi Locus Variable Number Tandem Repeat Analysis (MMLVA).

results1549-swabs were collected from 474-patients. Overall, 50/474(10.6%) were CD PCR-positive, 24/50 were colonized at admission, while 26/50 were first identified > = 72 hours after admission. Amongst the 50 CD PCR-positive patients, 90% were asymptomatically colonized and 80% of individuals carried toxigenic CD-strains, including ribotype-027 (5/45:11%). MMLVA revealed five-clusters involving 15-patients harboring toxigenic (4/5) and non-toxigenic CD strains (1/5). In two clusters, patients were CD positive on admission while in the other three clusters involving 10 patients, we observed CD transmission from asymptomatically colonized patients to 8 previously CD-negative patients.

conclusionsWe identified increasing rates of colonization during admission to medical wards. MMLVA typing effectively discriminated between strains and suggests that 20% of patients with CD colonization acquired their strain(s) from asymptomatically colonized individuals in hospital.

Indexed as

AdolescentAdultAgedAged, 80 and overCarrier StateClostridioides difficileClostridium InfectionsCross InfectionDiarrheaFecesFemaleHospitalizationHumansMaleMiddle AgedProspective Studies

Identifiers

PMID30742636
PMCPMC6370182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.